Article
Serum Estradiol and 20 Site-Specific Cancers in Women: Mendelian Randomization Study.
The Journal of clinical endocrinology and metabolism - 18 Jan 2022
Larsson Susanna C, Kar Siddhartha, Perry John R B, Carter Paul, Vithayathil Mathew, Mason Amy M, Easton Douglas F, Burgess Stephen
Abstract excerpt
CONTEXT: The causal role of endogenous estradiol in cancers other than breast and endometrial cancer remains unclear. OBJECTIVE: This Mendelian randomization study assessed the causal associations of endogenous 17β-estradiol (E2), the most potent estrogen, with cancer risk in women. METHODS: As primary genetic instrument, we used a genetic variant in the CYP19A1 gene that is strongly associated with serum E2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
